Coronavirus Safety - NAPNAP

Coronavirus Safety

As the COVID-19 pandemic continues to impact health and safety, the National Association of Pediatric Nurse Practitioners (NAPNAP) will continue to develop resources and curate information to support pediatric nurse practitioners, family nurse practitioners, other pediatric providers and patient families.


White Houses/HHS Summit

We Can Do This Summit: Conversations on Encouraging COVID-19 Vaccinations is a virtual Summit featuring conversations among leading health care professionals, parents and community leaders about COVID vaccines.

20:53– 53:33 – First panel: Don’t let COVID get in the way: Getting Children 5-11 Vaccinated, includes NAPNAP President Dr. Andrea Kline-Tilford

COVID Immunization Guidance Children 5-11 Years Old

Resources Related to Children 5-11 Immunization

Impact of the Pandemic on Mental Health

COVID-19 Vaccines for Adolescent Patients

To help you increase COVID-19 immunization rates in your practice and community, NAPNAP has developed a series of short videos to provide you with tools to effectively communicate with patient families about vaccine safety and efficacy, co-administering vaccines, vaccines for adolescents who have had COVID and vaccine hesitant families. Watch each video below or share the playlist with your colleagues.

NAPNAP Statements on COVID-19

NEW: Official statement on COVID-19 vaccine in children ages 5-11 years

Official statement on partnering with families and schools to promote safe return to in-person education

Download our templated letter for HCPs to send to local officials advocating for evidence-based mitigation strategies.

Download our templated letter for parents/caregivers to send to local officials advocating for evidence-based mitigation strategies.

Study: Exhausted and Burned Out: COVID-19 Emerging Impacts Threaten the Health of the Pediatric Advanced Practice Registered Nursing Workforce

Official statement calling for timely, efficient and equitable distribution of COVID-19 vaccines for children

Health Policy brief on Children’s Hospitals and Impact of COVID-19 – published in Journal of Pediatric Health Care

Association update on Government Relief Funds for Medicaid and CHIP Providers

Statement on Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19 Infection

Statement on Age Parameters During COVID-19 Pandemic

Statement on Immunizations During COVID-19 Outbreak

Statement on Fostering Child Health and Wellness During COVID-19 PandemicNE

TeamPeds Experts Live, Town Hall and Webinars

Watch on-demand:

TeamPeds Experts Live on How to Prepare for a Safe Return to School

Exploring the COVID-19 Vaccine Development and Approval Process for Adolescents webinar, hosted by the COVID-19 Vaccine Education and Equity Project

NAPNAP Child Health Policy Learning Collaborative telehealth webinar

Pediatric Primary and Acute Care Experiences During COVID-19 TeamPeds Town Hall

TeamPeds Town Hall on the COVID-19 Vaccine

Update from Dec. 1 ACIP COVID-19 meeting

Provider Wellbeing and Resiliency via TeamPeds Experts live on Facebook 

Keeping Kids Healthy at Home via TeamPeds Experts live on Facebook 

Transitioning to Telehealth via TeamPeds Experts live on Facebook 

Children’s Mental Health during COVID-19 via TeamPeds Experts live on Facebook 

Help Immunize in Your Community

As the vaccine supply increases, volunteers are needed to immunize people in communities across the country. Learn how you can volunteer in your state.

Provider Resources

NEW: COVID-19 Communications: Promoting Prevention Measures and Vaccine Confidence – NFID

NEW: COVID Vaccine Facts for Nurses – collaboration of 20 nursing organizations, including NAPNAP.

Strategies For Building Covid-19 Vaccine Confidence – The National Academies of Sciences, Engineering, Medicine

What Every Clinician Should Know about COVID-19 Vaccine Safety – CDC Dec. 14

Healthcare Professionals: Preparing for COVID-19 Vaccination – CDC

Use of Pfizer-BioNTech COVID-19 Vaccine: Clinical Considerations – CDC Dec. 12

COVID-19 and Flu Vaccine FAQ

Q: Can someone who is COVID positive get their influenza vaccine?
A: Yes, once their 10 day isolation is complete so that there isn’t unnecessary exposure to health care providers

Q: Is there a recommendation regarding how soon after a COVID-19 positive test should a person receive the influenza or other vaccine?
A: CDC recently addressed this on a call stating that patients who tested positive for COVID-19 should wait until they are finished with their isolation period to get their flu shot so as to not expose healthcare workers. However, once they are off isolation, they can get a flu shot then. 

Q: Can you discuss the optimal time to get the flu vaccine for maximum coverage throughout the flu season?
A: Sooner in the season is better. The goal is for everyone to have theirs no later than the end of October.

  • Immigrant Eligibility for Public Programs overview of available programs.
  • National Immigration Law Center FAQs related to COVID-19
  • Federal Emergency Management Agency (FEMA) Alternate Care Site (ACS) Toolkit to help state, local, tribal and territorial (SLTT) entities to address potential shortages in medical facilities during the 2020 COVID-19 pandemic. Note: large file may take a few minutes to open/download.
  • CDC general guidance and frequently asked questions for healthcare providers about the coronavirus.
  • CDC prevention and control recommendations for patients with suspected or confirmed coronavirus disease in healthcare settings.
  • American Association of Critical-Care Nurses “COVID-19 Pulmonary, ARDS and Ventilator Resources” education module.
  • Healio Q&A: Interim protocols for COVID-19 in primary care.
  • CMS guidelines for Medicare/Medicaid.
  • CMS summary of Regulatory Changes to Help U.S. Healthcare System Address COVID-19 Patient Surge – provisions include authorizing hospitals to use PAs and NPs to the fullest extent possible, in accordance with a state’s emergency preparedness or pandemic plan and ordering tests and medications that may have previously required a physician’s order where permitted under state law. Full information about waivers can be found on CMS’ webpage.
  • The Joint Commission FAQs about granting privileges during a disaster.
  • HHS has announced that HIPAA requirements for security will not be enforced against regulated professionals during the COVID-19 response, but the use of secure telecommunication methods remains well-advised and appropriate. Read more.
  •, a new interactive, web-based, knowledge-transfer platform offering online courses to improve the response to health emergencies from WHO.
  • NIMH resources for coping with stress and mental health during pandemic.
  • NPR COVID tracker by state.
  • NPR hospital capacity tracker.

Resources to Share with Families

What is the COVID-19 (coronavirus)?

COVID-19, or coronavirus, is a respiratory illness that can spread from person to person.  The virus that causes COVID-19 is a novel coronavirus that was first identified during an investigation into an outbreak in Wuhan, China.

How does the COVID-19 spread?

The virus that causes COVID-19 probably emerged from an animal source, but is now spreading from person to person. The virus is thought to spread mainly between people who are in close contact with one another (within about six feet) through respiratory droplets produced when an infected person coughs or sneezes. It also may be possible that a person can get COVID-19 by touching a surface or object that has the virus on it and then touching their own mouth, nose, or possibly their eyes, but this is not thought to be the main way the virus spreads. Visit the Centers for Disease Control and Prevention for up-to-date information.

What are severe complications from this virus?

Some patients have pneumonia in both lungs, multi-organ failure and in some cases death.  

Is there a vaccine/treatment?

The FDA has granted emergency use authorization for three COVID-19 vaccines, Pfizer-BioNTech, Moderna and Janssen. Pfizer-BioNTech has been authorized for individuals 12 years of age or older while Moderna and Janssen has been authorized for individuals 18 years of age or older. The best way to prevent infection is to take everyday preventive actions, like avoiding close contact with people who are sick and washing your hands often. There is no specific antiviral treatment for COVID-19. People with COVID-19 can seek medical care to help relieve symptoms.

CDC’s recommendations for protecting yourself and others include: frequently wash your hands with soap and water for at least 20 seconds; avoid touching your face; avoid close personal contact with others; and cover your mouth and nose when you cough or sneeze with a tissue or your inside of your elbow.

What is the difference between an antigen test and a PCR test? 

An antigen test looks for parts of the outside of the virus while a PCR test looks for part of the genetic material. This matters because if a test finds the COVID-19 genetic material, we can be more sure that it is really COVID-19. Antigen tests are not as accurate and need to be used carefully in certain circumstances.

Are there any antibody tests that are reliable? In what situation would it be appropriate to use one?

Antibody tests look for a immune system reaction to the virus. None of them are perfect. They cannot necessarily tell you for sure that you are immune to the virus or that you have never had the virus. Right now, antibody tests are most useful for looking at large groups of people and seeing if they have had many cases that were missed, but they are not very useful for individuals to make decisions about their own health.

Members in the Media

Several NAPNAP experts responded to media and stakeholder questions in print and digital interviews.

Archived Resources

Statement on Prioritizing Return to School for Children in COVID-19 Policy Planning – July 2020

Drs. Donna Hallas, Regena Spratling and Emily Cupelli issued a Safe turn to school: call to action published online in Contemporary Pediatrics on Aug. 5, 2020.

Dr. Mary Beth Koslap-Petraco, Dr. Donna Hallas and PNP Ann Taub provided guidance for Safe return to school: Part 2 published online in Contemporary Pediatrics on Aug. 19, 2020.

Legislation & Regulatory Information

This page contains content from a variety of sources. NAPNAP may be a distributor of content, not a publisher or author. Accordingly, any opinions, advice, statements, or other information expressed by any third parties are those of the respective author or publisher, not NAPNAP. NAPNAP is not responsible for the content, including the accuracy thereof.

Powered by

Website design and development by, Inc.